BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22094551)

  • 21. The selection of appropriate bacterial strains in preclinical evaluation of infection-resistant biomaterials.
    Campoccia D; Montanaro L; Moriarty TF; Richards RG; Ravaioli S; Arciola CR
    Int J Artif Organs; 2008 Sep; 31(9):841-7. PubMed ID: 18924097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foreign body infections due to Staphylococcus epidermidis.
    Uçkay I; Pittet D; Vaudaux P; Sax H; Lew D; Waldvogel F
    Ann Med; 2009; 41(2):109-19. PubMed ID: 18720093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging pathogenetic mechanisms of the implant-related osteomyelitis by Staphylococcus aureus.
    Montanaro L; Testoni F; Poggi A; Visai L; Speziale P; Arciola CR
    Int J Artif Organs; 2011 Sep; 34(9):781-8. PubMed ID: 22094557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 5-aminolevulinic acid-mediated photodynamic therapy on antibiotic-resistant staphylococcal biofilm: an in vitro study.
    Li X; Guo H; Tian Q; Zheng G; Hu Y; Fu Y; Tan H
    J Surg Res; 2013 Oct; 184(2):1013-21. PubMed ID: 23622723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of periprosthetic infections in the future: a review of new forms of treatment.
    George DA; Gant V; Haddad FS
    Bone Joint J; 2015 Sep; 97-B(9):1162-9. PubMed ID: 26330580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of microbial biofilms in prosthetic joint infections.
    Gbejuade HO; Lovering AM; Webb JC
    Acta Orthop; 2015 Apr; 86(2):147-58. PubMed ID: 25238433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The infected implant. Part 1: bacteriology].
    Geipel U; Herrmann M
    Orthopade; 2004 Dec; 33(12):1411-26; 1427-8. PubMed ID: 15551049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials.
    Arciola CR; Campoccia D; Speziale P; Montanaro L; Costerton JW
    Biomaterials; 2012 Sep; 33(26):5967-82. PubMed ID: 22695065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Orthopedic device-related infections].
    Ariza J; Euba G; Murillo O
    Enferm Infecc Microbiol Clin; 2008; 26(6):380-90. PubMed ID: 18588820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention and treatment of Staphylococcus aureus biofilms.
    Bhattacharya M; Wozniak DJ; Stoodley P; Hall-Stoodley L
    Expert Rev Anti Infect Ther; 2015; 13(12):1499-516. PubMed ID: 26646248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of bacterial biofilm on the treatment of prosthetic joint infections.
    Jacqueline C; Caillon J
    J Antimicrob Chemother; 2014 Sep; 69 Suppl 1():i37-40. PubMed ID: 25135088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sonication in the diagnosis of periprosthetic infections : Significance and practical implementation].
    Renz N; Cabric S; Janz V; Trampuz A
    Orthopade; 2015 Dec; 44(12):942-5. PubMed ID: 26572134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant-associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors.
    Nishitani K; Sutipornpalangkul W; de Mesy Bentley KL; Varrone JJ; Bello-Irizarry SN; Ito H; Matsuda S; Kates SL; Daiss JL; Schwarz EM
    J Orthop Res; 2015 Sep; 33(9):1311-9. PubMed ID: 25820925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From Koch's postulates to biofilm theory. The lesson of Bill Costerton.
    Ehrlich GD; Arciola CR
    Int J Artif Organs; 2012 Oct; 35(10):695-9. PubMed ID: 23138704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and management of prosthetic joint infection.
    Matthews PC; Berendt AR; McNally MA; Byren I
    BMJ; 2009 May; 338():b1773. PubMed ID: 19482869
    [No Abstract]   [Full Text] [Related]  

  • 36. [General principles of infection treatment in joint replacements].
    Landor I; Vavrík P; Jahoda D
    Acta Chir Orthop Traumatol Cech; 2005; 72(3):183-90. PubMed ID: 16105503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis and treatment concepts of orthopaedic biofilm infections.
    Zimmerli W; Moser C
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):158-68. PubMed ID: 22309166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of a cochlear implant biofilm infection: a potential role for alternative antimicrobial agents.
    Brady AJ; Farnan TB; Toner JG; Gilpin DF; Tunney MM
    J Laryngol Otol; 2010 Jul; 124(7):729-38. PubMed ID: 20214837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial coating agents: can biofilm formation on a breast implant be prevented?
    van Heerden J; Turner M; Hoffmann D; Moolman J
    J Plast Reconstr Aesthet Surg; 2009 May; 62(5):610-7. PubMed ID: 18359675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of N-acetyl-L-cysteine against biofilm of Staphylococcus aureus and Pseudomonas aeruginosa on orthopedic prosthetic materials.
    Drago L; De Vecchi E; Mattina R; Romanò CL
    Int J Artif Organs; 2013 Jan; 36(1):39-46. PubMed ID: 23280076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.